semaglutide dark side A potentially blinding condition is a very rare effect of the GLP-1 receptor agonist (Ozempic, Wegovy, Rybelsus), the European Medicines Agency (EMA) concluded. https://www.medpagetoday.com/ophthalmology/generalophthalmology/115938?trw=no Surge in fake Ozempic reveals

Youre never left in the dark

Nuevas molculas como retatrutida y mounjaro representan una tendencia clara: se buscan frmacos ms potentes, con efectos ms duraderos y menos riesgos

One theory is that Retatrutides stimulation of GLP-1, GIP, and glucagon receptors may interact with the autonomic nervous system, shifting the balance towards slightly increased sympathetic activity

Trial SELECT (Lincoff et al., NEJM 2023) Design Phase 3 / 39.8 mo mean follow-up Population 17,604 adults with CVD + overweight or obesity, no diabetes Key result 20% reduction in major heart events (HR 0.80

Claims for Psychiatric Harm While Taking Ozempic Patients taking Ozempic have reported psychiatric side effects

Stimulating insulin release and reducing glucagon to lower blood sugar levels